Related references
Note: Only part of the references are listed.Studies on the oridonin-loaded poly(D,L-lactic acid) nanoparticles in vitro and in vivo
Jie Xing et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2007)
Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma
Wen Xu et al.
ACTA PHARMACOLOGICA SINICA (2006)
Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-β-cyclodextrin
J Liu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Evaluation of cyclodextrin solubilization of drugs
T Loftsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Preformulation study of the inclusion complex warfarin-β-cyclodextrin
G Zingone et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-β-cyclodextrin
JH Kim et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation
CL Zhang et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
PC-SPES: Herbal formulation for prostate cancer
LS Marks et al.
UROLOGY (2002)
Share Paper
